Measuring a set of serum protein biomarkers is likely to improve diagnostic accuracy for Autism Spectrum Disorder (ASD) enabling early intervention for an improved outlook, according to a study from the Peter O''Donnell Jr. Brain Institute at UT Southwestern Medical Center. The study was published in the Journal of Neuroinflammation and is one of the many studies conducted that aim to improve early diagnosis of ASD by shifting focus to measurement of biomarkers, rather than relying on behavioral symptoms for diagnosis.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer